Ionis Director, Global HEOR, Rare Disease Immunology, Successfully Placed by The Chase Group

Ionis Director, Global HEOR, Rare Disease Immunology, Successfully Placed by The Chase Group

Director, Global HEOR Rare Disease Immunology reporting to Montserrat Vera-Llonch was filled for Ionis. This is a critical and significant role as the commercial function grows with the launch of one of the rare disease assets currently in Phase III. Montserrat’s team will lead development of global HEOR research strategies and plans. The Chase Group wishes the team much success in this strategic role! To learn more, email moira@chasegroup.com